羚锐制药 (600285)
Henan Lingrui Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 56711.55
- Circulating A-Shares(W): 56586.55
- Earnings Per Share(RMB): 1.1480
- Net Assets Per Share(RMB): 5.7277
- Operating Revenue(W RMB): 304136.16
- Total Profit(W RMB): 75755.88
- **Net Profit Attributable to Parent(W RMB) **: 65093.26
- Net Profit Growth Rate(%): 13.43
- Weighted Return on Equity(%): 20.4000
- Operating Cash Flow Per Share(RMB): 0.8650
- Undistributed Profit Per Share(RMB): 3.6042
- Capital Reserve Per Share(RMB): 0.6358
2. Main Business
The main business covers:
- Production and sales of traditional Chinese medicine hard plasters
- Production and sales of granules
- Production and sales of liniments, tablets, capsules, etc.
3. Company Basic Information
- Company Name: Henan Lingrui Pharmaceutical Co., Ltd.
- Listing Date: 2000-10-18
- Industry: Pharmaceutical Manufacturing
- Address: No. 666 Jiangjun Road, Xinxian County, Xinyang City, Henan Province
- Website: http://www.lingrui.com
- Company Profile: The company's predecessor was Henan Lingrui Pharmaceutical Co., Ltd., which was jointly invested and established by Xinyang Lingyangshan Pharmaceutical Factory and Hong Kong Rui Xing Enterprise Company with a registered capital of 2.98 million yuan. From March to April 1993, the company underwent equity transfers, after which it became a limited liability company composed of six shareholders including Xinyang Lingyangshan Pharmaceutical Factory, Henan Xinyang Xinsheng Pharmaceutical Co., Ltd., and Hong Kong Rui Xing Enterprise Company. On June 13, 1999, Henan Lingrui Pharmaceutical Co., Ltd. was wholly restructured into a joint stock company with a total share capital of 60.36 million shares. After issuing 40 million shares of RMB common stock to the public on September 14, 2000, the company's total share capital reached 100.36 million shares.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Henan Lingrui Group Co., Ltd. | Corporate Legal Person | 12181.79 | 21.53 |
| 2 | New China Life Insurance Co., Ltd. - Traditional - Ordinary Insurance Product - 018L-CT001 Shanghai | Insurance | 1016.96 | 1.80 |
| 3 | E Fund Management Co., Ltd. - China Life Insurance Company Limited - Traditional Insurance - E Fund China Life Shares Balanced Stock Traditional Available-for-Sale Single Asset Management Plan | Asset Management Plan | 809.39 | 1.43 |
| 4 | E Fund Management Co., Ltd. - China Life Insurance Company Limited - Participating Insurance - E Fund China Life Shares Balanced Stock Portfolio Single Asset Management Plan (Available-for-Sale) | Asset Management Plan | 801.74 | 1.42 |
| 5 | Qianhai Kaiyuan China Scarce Asset Flexible Allocation Mixed Securities Investment Fund Class A | Fund | 730.14 | 1.29 |
| 6 | Qianhai Kaiyuan National Comparative Advantage Flexible Allocation Mixed Securities Investment Fund Class A | Fund | 652.68 | 1.15 |
| 7 | Yinhua CSI Innovative Pharmaceutical Industry Exchange Traded Open-End Index Securities Investment Fund | Fund | 440.50 | 0.78 |
| 8 | Basic Pension Insurance Fund Portfolio 805 | Social Security Fund | 433.93 | 0.77 |
| 9 | Hua'an Qianyu Bond Initiation Securities Investment Fund Class A | Fund | 430.00 | 0.76 |
| 10 | Southern CSI 1000 Exchange Traded Open-End Index Securities Investment Fund | Fund | 415.07 | 0.73 |
5. Concept Sectors
- Innovative Drugs
- Margin Trading & Securities Lending
- Insurance Heavy Positions
- High-Performance Stocks
- Social Security Fund Heavy Positions
- Pension Funds
- Sustained Growth
- Proposed Reduction
- High Dividend Stocks
- SSE Governance
- SSE 380
- National Credit Value
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information